Results 31 to 40 of about 491,654 (151)

Inflammaging in the pathogenesis of chronic non­communicable diseases

open access: yesКардиоваскулярная терапия и профилактика, 2021
See Krivoshapova K. E., Masenko V. L., Bazdyrev E. D., Barbarash O. L. Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues in Review articles, pp. 92­98.
O. T. Kim
doaj   +1 more source

Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults – The Yishun Study

open access: yesOsteoporosis and Sarcopenia, 2021
Objectives: To 1) report prevalence of ‘osteosarcopenia’ (OS) and osteosarcopenic obesity (OSO) entities using evidence-based diagnostic techniques and definitions, 2) examine if OSO offers additional predictive value of functional decline over its ...
Benedict Wei Jun Pang   +9 more
doaj   +1 more source

A Clinical Study of Structural Properties of Osteosarcopenic Obesity Syndrome Using Multivariate Statistical Methods [PDF]

open access: yesZhongguo quanke yixue, 2022
Background Osteosarcopenic obesity syndrome (OSO) is a disease that seriously endangers the health of older people. The rational classification of the disease can guide the clinical diagnosis and treatment.
Yizhen NIE, Zhaoqi YAN, Wei YAN, Hongmei FU, Xingjuan ZHAO, Hui YIN, Qunhong WU
doaj   +1 more source

Understanding the Consequences of Fatty Bone and Fatty Muscle: How the Osteosarcopenic Adiposity Phenotype Uncovers the Deterioration of Body Composition

open access: yesMetabolites, 2023
Adiposity is central to aging and several chronic diseases. Adiposity encompasses not just the excess adipose tissue but also body fat redistribution, fat infiltration, hypertrophy of adipocytes, and the shifting of mesenchymal stem cell commitment to ...
Kelsey Hu   +9 more
doaj   +1 more source

Osteosarcopenic Obesity Syndrome: What Is It and How Can It Be Identified and Diagnosed? [PDF]

open access: yesCurr Gerontol Geriatr Res, 2016
Conditions related to body composition and aging, such as osteopenic obesity, sarcopenia/sarcopenic obesity, and the newly termed osteosarcopenic obesity (triad of bone muscle and adipose tissue impairment), are beginning to gain recognition. However there is still alack of definitive diagnostic criteriafor these conditions.
Ilich JZ, Kelly OJ, Inglis JE.
europepmc   +5 more sources

Association Between Sarcopenia and Fracture Risk in a Population From the UK Biobank Database

open access: yesJournal of Bone and Mineral Research, Volume 38, Issue 10, Page 1422-1434, October 2023., 2023
ABSTRACT Studies on the fracture risk in presarcopenic and sarcopenic patients report contradictory results. The objective was to assess whether presarcopenia and sarcopenia are associated with an increase in fracture risk. We conducted a retrospective study using the UK Biobank cohort and the European Working Group on Sarcopenia in Older People 2 ...
Charlotte Jauffret   +5 more
wiley   +1 more source

Weight‐adjusted waist as an integrated index for fat, muscle and bone health in adults

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 14, Issue 5, Page 2196-2203, October 2023., 2023
Abstract Background Unhealthy body composition, including high fat mass, low muscle mass and low bone mass, is a critical health issue in adults. The weight‐adjusted waist index (WWI) estimates fat and muscle mass and may have implications for bone health.
Kyoung Jin Kim   +4 more
wiley   +1 more source

Sarcopenic obesity in liver disease: Handling both sides of the penny

open access: yesPortal Hypertension &Cirrhosis, Volume 1, Issue 1, Page 42-56, June 2022., 2022
The multifactorial and complicated pathogenesis of sarcopenic obesity in the context of liver diseases. Abstract Skeletal muscle and fat tissue show distinct pathophysiological roles and pivotal functions. The culmination of muscle wasting and fat accumulation represents an opposite terminal of each state.
Yangyang Hui   +10 more
wiley   +1 more source

Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 13, Issue 1, Page 368-376, February 2022., 2022
Abstract Background Sarcopenic obesity aims to capture the risk of functional decline and cardiometabolic diseases, but its operational definition and associated clinical outcomes remain unclear. Using data from the Longitudinal Aging Study of Taipei, this study explored the roles of the muscle‐to‐fat ratio (MFR) with different definitions and its ...
Pei‐Chin Yu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy